PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Practice Signal

Pharmacist Prescribing and Test-and-Treat Models

This review helps pharmacists judge which protocol-based prescribing and test-and-treat services have supporting evidence, and which design and governance elements determine whether they work in practice.

Bottom Line

Across community strep testing, emergency department culture callbacks, post-discharge result review, and remote blood pressure management, pharmacist prescribing under protocols shows consistent process gains, but the evidence is low certainty, outcome benefit is unproven, and success depends more on infrastructure, triage rules, and patient follow-through than on pharmacist clinical willingness.

0.30
AOR, pharmacy antibiotic provision
91%–97%
managed without GP referral
53.8
point gain, appropriate therapy
−3.4 mmHg
extra systolic drop, RPM completers

State of Play

Pharmacist prescribing under protocols and collaborative practice agreements (CPAs) is broadly accepted for low-risk, protocol-driven conditions, and support drops for complex or high-risk therapy. The current evidence base is almost entirely observational, descriptive, or qualitative, graded low or very low, and it consistently measures process (antibiotic supply, appropriateness, protocol adherence, blood pressure change) rather than patient outcomes.

🔒
Full Analysis: Subscribers Only
The complete evidence synthesis, practice recommendations, and open questions.
What Changed
How It Fits the Guidelines
Effect chart & evidence comparison
Evidence at a Glance
Practice Considerations
Open Questions
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this Practice Signal, every other Signal, and every deep analysis we publish, plus PDF reports.

Subscribe for $8/month →
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.
pharmacist prescribing collaborative practice agreement test-and-treat streptococcal pharyngitis rapid antigen detection test FeverPAIN Centor antimicrobial stewardship urinary tract infection ESBL nitrofurantoin fluoroquinolones
🎓
Synthesized and reviewed by a licensed pharmacist
Each Practice Signal is built from our published deep analyses and checked for clinical accuracy before it goes live.
Not medical advice. PharmD Signal provides educational synthesis of published pharmacy and medical literature for practicing pharmacists. It is not a treatment recommendation for any individual patient; clinical decisions remain the responsibility of the treating clinician exercising independent professional judgment.
Thanks for the feedback!

← Back to Evidence Rounds